did the fda ban compounded semaglutide ๐จ Moves to Permanently Shut Down GLP-1s FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Despite FDA ruling, compounded GLP-1s
Description
International Parkinson and Movement Disorder Society Fascinating how we keep discussing therapeutic targets for disease modification while rarely acknowledging that Parkinsons is not a biologically homogeneous disease but a syndrome

Unused, leftover, or expired medications must be disposed of properly so they cannot cause harm to someone else

Front Endocrinol (Lausanne) 2018;9:672.ArticlePubMedPMC 9
Malignancies Inflamm Bowel Dis Digestion
It may also request more data, labeling changes, or manufacturing clarifications before making a decision

1.1 Data collection dates: January 27, 2025-July 23, 2025
